Peter A Merkel

Peter A Merkel

UNVERIFIED PROFILE

Are you Peter A Merkel?   Register this Author

Register author
Peter A Merkel

Peter A Merkel

Publications by authors named "Peter A Merkel"

Are you Peter A Merkel?   Register this Author

100Publications

2463Reads

-Profile Views

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis.

J Rheumatol 2019 Mar 1. Epub 2019 Mar 1.

From the Department of Epidemiology and Biostatistics, Faculty of Medicine, University of Iceland, Reykjavik; Department of Rheumatology and Centre for Rheumatology Research, University Hospital, Iceland; Division of Rheumatology, Division of General Internal Medicine, Department of Family Medicine and Community Health & Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA; Department of Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, USA; University of Pennsylvania, Philadelphia, PA; Nuffield Department of Population Health (HSRU), University of Oxford, Old Road Campus, Oxford; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Rheumatology, University of Ottawa, Ottawa, Canada; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, ON,;Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada; Faculty of Health and Applied Sciences, University of the West of England, Bristol and School of Clinical Sciences, University of Bristol, Bristol, UK; Division of Rheumatology, Mount Sinai Hospital, Toronto, ON; Division of Rheumatology, University of Utah, Salt Lake City, UT; Department of Rheumatology, Cleveland Clinic, Cleveland, OH; Section of Rheumatology, Boston University School of Medicine, Boston; Division of Pulmonology and Critical Care Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. This work was supported by The Vasculitis Clinical Research Consortium (VCRC) (U54 AR057319 and R01 AR 064153) which is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Science (NCATS). The VCRC is funded through collaboration between NCATS, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and has received funding from the National Center for Research Resources (U54 RR019497). Additional support for this work was provided by a contract from the Patient-Centered Outcomes Research Institute (IP2PI000603 ). Address correspondence to Gunnar Tomasson, Assistant professor of epidemiology, Faculty of Medicine, University of Iceland. Sturlugata 8, 101 Reykjavik, Iceland. E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171405DOI Listing
March 2019

Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-Vessel Vasculitis.

J Rheumatol 2019 Mar 15. Epub 2019 Mar 15.

Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA; Division of Rheumatology, Georgetown University, Washington DC, USA; National Institutes of Health, Clinical Center, Radiology and Imaging Sciences, Bethesda, MD, USA; Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA. Address correspondence to Peter C. Grayson, MD, MSc, National Institutes of Health / NIAMS, 10 Center Drive, Building 10, 10N Rm 311D, Bethesda, MD 20892 Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181222DOI Listing
March 2019

Update on Outcome Measure Development in Large-Vessel Vasculitis: Report from OMERACT 2018.

J Rheumatol 2019 Mar 15. Epub 2019 Mar 15.

From the Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, University of California at Los Angeles, Los Angeles, CA, USA; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, School of Medicine, Fatih Sultan Mehmet Training and Research Hospital, Istanbul; Division of Rheumatology, Marmara University, School of Medicine, Marmara, Turkey; Department of Internal Medicine, University Paris Diderot, Paris, France; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK; Honorary Consultant Rheumatologist, Leeds Teaching Hospitals NHS Trust, Leeds; University Hospitals Bristol NHS Trust, Bristol, UK; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program and the Division of Rheumatology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. This work was funded in part by the Vasculitis Clinical Research Consortium (VCRC). The VCRC is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Science (NCATS). The VCRC is funded through collaboration between NCATS, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), U54 AR057319), and has received funding from the National Center for Research Resources (U54 RR019497). Address correspondence to Peter A. Merkel, MD, MPH Chief, Division of Rheumatology Professor of Medicine and Epidemiology University of Pennsylvania, Philadelphia, PA 19104. E-mail:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181072
Publisher Site
http://dx.doi.org/10.3899/jrheum.181072DOI Listing
March 2019

Updating OMERACT Core Set of Domains for ANCA-Associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability and Health.

J Rheumatol 2019 Feb 1. Epub 2019 Feb 1.

Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Ottawa / the Ottawa Hospital, Ottawa, Ontario, Canada; Faculty of Health and Applied Science, University of the West of England, Bristol, UK; School of Clinical Science, University of Bristol, Bristol, UK; Maastricht University Medical Centre, Maastricht, the Netherlands; Caphri Research Institute, Maastricht University, Maastricht, The Netherlands; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Nuffield Department of Population Health (HSRU), University of Oxford, Oxford, UK; Department of Epidemiology and Biostatistics, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Rheumatology, University Hospital, Reykjavik, Iceland; Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, PolicyLab, Children's Hospital of Philadelphia, 2716 South St, Philadelphia, PA 19146, USA; Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA, USA. The Vasculitis Clinical Research Consortium (VCRC) Outcome Measures in Rheumatology Vasculitis Working Group was supported by the Vasculitis Clinical Research Consortium, which received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grants U54-AR-057319 and U01-AR-51874 04), the National Center for Research Resources (grant U54-RR-019497), the National Center for Advancing Translational Science, the Office of Rare Diseases Research, each part of the United States National Institutes of Health (NIH). The VCRC is a member of the NIH Rare Diseases Clinical Research Network. The VCRC also received a Pilot award from the Patient-Centered Outcomes Research Institute. Dr. Milman's work was supported by a postgraduate Rheumatology Fellowship award given jointly by UCB Pharma, the Canadian Rheumatology Association, and The Arthritis Society, and a Fellowship from the Ottawa Hospital Department of Medicine. This work was further supported by a Vasculitis Foundation Research Grant. Address correspondence to Nataliya Milman, The Ottawa Hospital, Riverside Campus, 1967 Riverside Drive, Ottawa, ON K1H7W9, Canada. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181073DOI Listing
February 2019

Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes.

Patient Relat Outcome Meas 2019 8;10:37-42. Epub 2019 Feb 8.

Nuffield Department of Population Health (HSRU), University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PROM.S163601DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372855PMC
February 2019

Patient involvement in medical research: what patients and physicians learn from each other.

Orphanet J Rare Dis 2019 01 24;14(1):21. Epub 2019 Jan 24.

Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, White Building, 5th Floor 3400 Spruce Street, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-018-0969-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346573PMC
January 2019

Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis.

Steroids 2018 12 21;140:159-166. Epub 2018 Oct 21.

ReveraGen BioPharma, 155 Gibbs St., Suite 433, Rockville, MD 20850, USA; School of Pharmacy and Pharmaceutical Sciences, Binghamton University - SUNY, 4400 Vestal Pkwy E, Binghamton, NY 13902, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0039128X183019
Publisher Site
http://dx.doi.org/10.1016/j.steroids.2018.10.008DOI Listing
December 2018

Ascending Aortic Aneurysm Secondary to Isolated Noninfectious Ascending Aortitis.

J Clin Rheumatol 2018 Dec 5. Epub 2018 Dec 5.

Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000948DOI Listing
December 2018

Characterisation of the nasal microbiota in granulomatosis with polyangiitis.

Ann Rheum Dis 2018 Oct 11;77(10):1448-1453. Epub 2018 Jul 11.

Division of Rheumatology and the Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-213645DOI Listing
October 2018

Health-related outcomes of importance to patients with Takayasu's arteritis.

Clin Exp Rheumatol 2018 Mar-Apr;36 Suppl 111(2):51-57. Epub 2017 Sep 18.

The University of Pennsylvania, Division of Family Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
July 2018

Impact of vasculitis on employment and income.

Clin Exp Rheumatol 2018 Mar-Apr;36 Suppl 111(2):58-64. Epub 2018 Jan 10.

Vasculitis clinic, Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003628PMC
July 2018

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

J Rheumatol 2017 Dec 1;44(12):1933-1937. Epub 2017 Sep 1.

From the Division of Rheumatology, and Department of Family Medicine and Community Health, and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Rheumatology, University of California at Los Angeles, Los Angeles, California, USA; Fatih Sultan Mehmet Training and Research Hospital; Division of Rheumatology, Department of Internal Medicine, Istanbul University Faculty of Medicine; Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey; Division of Rheumatology, University of Ottawa; Division of Rheumatology, The Ottawa Hospital; Department of Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Internal Medicine, University Paris Diderot, Paris, France; University of the West of England; University of Bristol; University Hospitals Bristol National Health Service (NHS) Trust, Bristol, UK; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712274PMC
December 2017

Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.

J Rheumatol 2017 Dec 1;44(12):1928-1932. Epub 2017 Sep 1.

From the Division of Rheumatology, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey; Division of Rheumatology, and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161269DOI Listing
December 2017

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

J Rheumatol 2017 Nov 1;44(11):1750-1753. Epub 2017 Apr 1.

From the Division of Rheumatology, Department of Internal Medicine, Istanbul University Cerrahpasa Faculty of Medicine; Division of Rheumatology, Marmara University Faculty of Medicine; Division of Rheumatology, Department of Internal Medicine, Istanbul University Istanbul Faculty of Medicine; Academic Hospital, Istanbul, Turkey; Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, Ohio; Department of Family Medicine and Community Health, University of Pennsylvania; Division of Rheumatology, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania; New York University School of Medicine, NYU Hospital for Joint Diseases, New York, USA; Department of Internal Medicine, University Paris Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161352DOI Listing
November 2017

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis.

Rheumatology (Oxford) 2017 11;56(11):1962-1969

Norwich Medical School, University of East Anglia, Norwich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex293DOI Listing
November 2017

The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.

J Rheumatol 2017 Oct 1;44(10):1515-1521. Epub 2017 Aug 1.

From the Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, and UK National Institute for Health Research (NIHR), Leeds; Academic Unit of Primary Medical Care, University of Sheffield, Sheffield; PMR-GCA Scotland, Dundee; PMR-GCA North East, Gateshead; Primary Care and Health Sciences, Keele University, Keele; Norfolk and Norwich University Hospital, Norwich, UK; Ottawa Hospital Research Institute and School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, Ontario, Canada; Discipline of Medicine, The University of Adelaide; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia; Division of Rheumatology, University of California Los Angeles (UCLA), Los Angeles, California; Division of Rheumatology and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania; SDG LLC, Cambridge, Massachusetts, USA; Department of Rheumatology and Clinical Immunology, Charite University Hospital Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161109DOI Listing
October 2017

Severe Infection in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

J Rheumatol 2017 Oct 1;44(10):1468-1475. Epub 2017 Aug 1.

From Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, and Orthopedics, Clinical Epidemiology Unit, and Section of Nephrology, Lund; Department of Medicine and Nephrology, Linköping University, Linköping, Sweden; Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160909DOI Listing
October 2017

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

J Rheumatol 2017 Oct 1;44(10):1529-1535. Epub 2017 Sep 1.

From the University of the West of England; University of Bristol; University Hospitals Bristol UK National Health Service (NHS) Trust, Bristol; Nuffield Department of Population Health, University of Oxford; Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Division of Rheumatology, University of Ottawa; Division of Rheumatology, The Ottawa Hospital; Department of Clinical Epidemiology, Ottawa Hospital Research Institute; Ottawa Hospital Research Institute, School of Epidemiology, Public Health and Preventative Medicine, Faculty of Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, University of Ottawa; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada; Division of Rheumatology, Maastricht University Medical Centre; Caphri Graduate School, Maastricht, the Netherlands; Vasculitis Foundation, Denver, Colorado; Department of Family Medicine and Community Health, University of Pennsylvania; Epidemiology, Neurology, and Anesthesiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania; Department of Medicine, University of Pennsylvania; Clinical Medicine, Division of Rheumatology, University of Pennsylvania; Medicine and Epidemiology, Division of Rheumatology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, Florida; Division of Rheumatology, Department of Medicine, University of California, Los Angeles, USA; Division of Rheumatology, Marmara University, School of Medicine, Marmara, Turkey; Medicine, Hopital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.161139
Publisher Site
http://dx.doi.org/10.3899/jrheum.161139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951181PMC
October 2017

Variation in the Treatment of Children Hospitalized With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the US.

Arthritis Care Res (Hoboken) 2017 09 13;69(9):1377-1383. Epub 2017 Aug 13.

Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415438PMC
September 2017

Response to eLetter: 'Infections in giant cell arteritis and therapeutic implications' by Moiseev .

Ann Rheum Dis 2017 Sep 17;76(9):e30. Epub 2017 Jan 17.

University of Iceland, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-210976DOI Listing
September 2017

Patient-reported outcomes in Takayasu's arteritis.

Presse Med 2017 Jul - Aug;46(7-8 Pt 2):e225-e227. Epub 2017 Jul 26.

Marmara university, school of medicine, division of rheumatology, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2017.03.023DOI Listing
September 2017

Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis.

Clin Exp Rheumatol 2017 Mar-Apr;35 Suppl 103(1):202-208. Epub 2016 Oct 6.

Division of Rheumatology, Department of Paediatrics, Children's Hospital of Philadelphia; and Department of Paediatrics, Center for Paediatric Clinical Effectiveness, Children's Hospital of Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382123PMC
July 2017

Reply.

Arthritis Rheumatol 2017 Jul 10;69(7):1505-1506. Epub 2017 May 10.

University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40107DOI Listing
July 2017

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?

Rheumatology (Oxford) 2017 07;56(7):1154-1161

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251621PMC
July 2017

Infections and the risk of incident giant cell arteritis: a population-based, case-control study.

Ann Rheum Dis 2017 Jun 28;76(6):1031-1035. Epub 2016 Nov 28.

Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-210152DOI Listing
June 2017

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

N Engl J Med 2017 05;376(20):1921-1932

From the Department of Medicine, National Jewish Health, Denver (M.E.W.); the Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, La Jolla (P.A.); Beth Israel Deaconess Medical Center, Boston (P.A., P.F.W.); the Department of Medicine, University of Cambridge, Cambridge (D.J.), the Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford (R.L.), Research and Development, Immuno-Inflammation Therapy Area Unit (J.B.), and Research and Development, Statistics, Programming, and Data Standards (S.M.), GlaxoSmithKline, Uxbridge, and Trizell, Oxford (R.P.) - all in the United Kingdom; the Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (P.K., A.K.); the Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland (C.A.L.); the Division of Rheumatology and the Department of Biostatistics and Clinical Epidemiology, University of Pennsylvania (P.A.M.), and the Respiratory Therapy Area Unit and Flexible Discovery Unit, GlaxoSmithKline (J.S.), Philadelphia; Rheumazentrum, Schleswig-Holstein Mitte, Neumünster, Germany (F.M.); the Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN (U.S.); the Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clinic University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona (M.C.C.); the Respiratory Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC (S.W.Y.); and the Departments of Dermatology and Medicine, University of Utah School of Medicine, Salt Lake City (G.J.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548295PMC
May 2017

The association of vascular risk factors with visual loss in giant cell arteritis.

Rheumatology (Oxford) 2017 04;56(4):524-528

Norwich Medical School, University of East Anglia, Norwich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew397DOI Listing
April 2017

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.

Sci Rep 2017 03 9;7:43953. Epub 2017 Mar 9.

Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep43953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344032PMC
March 2017

Patient-Reported Outcomes in Glomerular Disease.

Clin J Am Soc Nephrol 2017 01 3;12(1):140-148. Epub 2016 Jun 3.

Division of Nephrology, Department of Pediatrics and Communicable Diseases, C.S. Mott Children's Hospital and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.13231215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220669PMC
January 2017

Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.

J Rheumatol 2017 01 1;44(1):84-90. Epub 2016 Nov 1.

From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160249DOI Listing
January 2017

Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.

Arthritis Rheumatol 2017 01;69(1):176-184

Massachusetts General Hospital, Harvard Medical School, and Boston University School of Medicine, Boston.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.39847
Publisher Site
http://dx.doi.org/10.1002/art.39847DOI Listing
January 2017

Diffuse atrophic papules and plaques, intermittent abdominal pain, paresthesias, and cardiac abnormalities in a 55-year-old woman.

J Am Acad Dermatol 2016 Dec 4;75(6):1274-1277. Epub 2016 Oct 4.

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2016.09.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112129PMC
December 2016

Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.

J Rheumatol 2016 08 1;43(8):1559-65. Epub 2016 Jun 1.

From the Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital, Helsingborg; Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; Department of Clinical Sciences, Orthopaedics and Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK.M. Saleh, MD, Department of Internal Medicine, Section of Rheumatology, Helsingborg Hospital; C. Turesson, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Malmö, Rheumatology, Malmö; M. Englund, MD, PhD, Department of Clinical Sciences, Orthopaedics, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; A.J. Mohammad, MD, PhD, Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, and the Vasculitis and Lupus Clinic, Addenbrooke's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151033DOI Listing
August 2016

Comorbidities in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis versus the General Population.

J Rheumatol 2016 08 1;43(8):1553-8. Epub 2016 Jun 1.

From the Clinical Epidemiology Unit, Orthopaedics, Clinical Sciences Lund, and Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund; Department of Nephrology, Linköping University, Linköping, Sweden; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland; the Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK.M. Englund, MD, PhD, Clinical Epidemiology Unit, Orthopaedics, Clinical Sciences Lund, Lund University, and Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; P.A. Merkel, MD, MPH, Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania; G. Tomasson, MD, Department of Public Health Sciences, University of Iceland; M. Segelmark, MD, PhD, Department of Nephrology, Linköping University; A.J. Mohammad, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, and the Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151151DOI Listing
August 2016

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.

J Rheumatol 2016 06 1;43(6):1078-84. Epub 2016 Apr 1.

From the Division of Rheumatology, University of California, Los Angeles, Los Angeles, California; Department of Biostatistics, University of South Florida, Tampa, Florida, USA; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; Division of Rheumatology and Clinical Immunology, University of Pennsylvania, Philadelphia, Pennsylvania; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.T.A. Kermani, MD, MS, Division of Rheumatology, University of California, Los Angeles; D. Cuthbertson, MS, Department of Biostatistics, University of South Florida; S. Carette, MD, FRCPC, Division of Rheumatology, Mount Sinai Hospital; G.S. Hoffman, MD, MS, Center for Vasculitis Care and Research, Cleveland Clinic; N.A. Khalidi, MD, FRCPC, Division of Rheumatology, St. Joseph's Healthcare, McMaster University; C.L. Koening, MD, MS, Division of Rheumatology, University of Utah; C.A. Langford, MD, MHS, Center for Vasculitis Care and Research, Cleveland Clinic; K. McKinnon-Maksimowicz, DO, Division of Rheumatology, University of Pittsburgh; C.A. McAlear, MA, Division of Rheumatology and Clinical Immunology, University of Pennsylvania; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; P. Seo, MD, MHS, Division of Rheumatology, Johns Hopkins University; K.J. Warrington, MD, Division of Rheumatology, Mayo Clinic

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891218PMC
June 2016

Reenergizing Research While Improving Patient Care.

Provider 2016 Jun;42(6):37-8, 41, 43 passim

View Article

Download full-text PDF

Source
June 2016

The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network.

Orphanet J Rare Dis 2016 05 18;11(1):66. Epub 2016 May 18.

Health Informatics Institute and Department of Pediatrics, University of South Florida, 3650 Spectrum Boulevard, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-016-0445-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870759PMC
May 2016

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

PLoS One 2015 26;10(3):e0121737. Epub 2015 Mar 26.

1st Medical Department and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital, Vienna, Austria; Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121737PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374913PMC
March 2016

Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis.

Joint Bone Spine 2016 Mar 8;83(2):207-11. Epub 2015 Dec 8.

Division of Rheumatology, University of Pennsylvania, 3600 Spruce Street, Philadelphia PA 19104, United States; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia 19104, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2015.04.021DOI Listing
March 2016

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature.

Semin Arthritis Rheum 2016 Feb 26;45(4):475-82. Epub 2015 Jul 26.

Division of Rheumatology, Mount Sinai Hospital, University of Toronto, The Joseph and Wolf Lebovic Building, 60 Murray St, Ste 2-220, Toronto, Ontario, Canada M5T 3L9. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2015.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982464PMC
February 2016

A small n sequential multiple assignment randomized trial design for use in rare disease research.

Contemp Clin Trials 2016 Jan 14;46:48-51. Epub 2015 Nov 14.

Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2015.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695231PMC
January 2016

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.

J Rheumatol 2015 Dec 15;42(12):2465-9. Epub 2015 Jun 15.

From the Division of Rheumatology, Koc University Faculty of Medicine, Istanbul; Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey; Division of Rheumatology, and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, Istanbul University Istanbul Faculty of Medicine; Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey; Division of Rheumatology, University of California, Los Angeles, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Department of Internal Medicine, University Paris Diderot, Paris, France; Division of Rheumatology, Ohio State University, Columbus, Ohio, USA; Division of Rheumatology, University of Ottawa, Ottawa, Ontario, Canada; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland.S.Z. Aydin, MD, Associate Professor, Division of Rheumatology, Koc University Faculty of Medicine; H. Direskeneli, MD, Professor of Rheumatology, Division of Rheumatology, Marmara University Faculty of Medicine; A. Sreih, MD, Assistant Professor of Medicine, Division of Rheumatology, University of Pennsylvania; F. Alibaz-Oner, MD, Division of Rheumatology, Marmara University Faculty of Medicine; A. Gul, Professor, Division of Rheumatology, Istanbul University Istanbul Faculty of Medicine; S. Kamali, Professor, Division of Rheumatology, Marmara University Faculty of Medicine; G. Hatemi, Associate Professor, Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine; T. Kermani, MD, MS, Assistant Clinical Professor, Division of Rheumatology, University of California at Los Angeles; S.L. Mackie, BM, BCh, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; A. Mahr, MD, PhD, Professo

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668221PMC
December 2015

Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

J Rheumatol 2015 Dec 15;42(12):2436-41. Epub 2015 Sep 15.

From the Division of Rheumatology, Department of Internal Medicine, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul; Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey; Department of Internal Medicine, University Paris Diderot, Paris, France; Division of Rheumatology, Koc University Faculty of Medicine, Istanbul; Faculty of Health Sciences, Marmara University; Department of Psychology, Istanbul University, Istanbul, Turkey; Celgene Corporation, Warren, New Jersey; Rutgers, Robert Wood Johnson Medical School, Department of Rheumatology, New Brunswick, New Jersey; Division of Rheumatology and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.G. Hatemi, MD, Associate Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, Istanbul University Cerrahpasa Faculty of Medicine; Y. Ozguler, MD, Fellow in Rheumatology, Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine; H. Direskeneli, MD, Professor of Rheumatology, Division of Rheumatology, Marmara University Faculty of Medicine; A. Mahr, MD, PhD, Professor of Internal Medicine, Department of Internal Medicine, University Paris Diderot; A. Gul, MD, Professor of Rheumatology, Division of Rheumatology, Department of Internal Medicine, Istanbul University; V. Levi, BA, Patient Research Partner, Istanbul; S.Z. Aydin, MD, Associate Professor of Rheumatology, Division of Rheumatology, Koc University Faculty of Medicine; G. Mumcu, DDS, PhD, Professor in Health Management, Faculty of Health Sciences, Marmara University; O. Sertel-Berk, MA, Associate Professor of Psychology, Department of Psychology, Istanbul University; R.M. Stevens, MD, Celgene Corporation, and Clinical Professor of Medicine, Rutgers, Robert Wood Johnson Medical School, Department of Rheumatology; H. Yazici, MD, Professor of Rheumatology, Division of Rheumatology, Department of Internal Medicine, Istanbul Universit

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940045PMC
December 2015

Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.

J Rheumatol 2015 Nov 1;42(11):2204-9. Epub 2015 Sep 1.

From the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, UK; Division of Rheumatology, University of Ottawa, Ottawa, Ontario, Canada; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland; Nuffield Department of Population Health (HSRU), University of Oxford, Oxford, UK; Department of Family Medicine and Community Health, and Division of Rheumatology and Department of Biostatistics and Epidemiology, University of Pennsylvania, and Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Departments of Epidemiology and Biostatistics; and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, University Maastricht, Maastricht, The Netherlands; Vasculitis Foundation, Denver, Colorado, USA; Division of Biostatistics and Informatics, Department of Pediatrics, College of Medicine, University of South Florida, Tampa, Florida, USA; Vasculitis Clinical Research Consortium, and Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.J.C. Robson, MBBS, PhD, Clinical Lecturer in Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford; N. Milman, MD, FRCPC, Clinical Lecturer in Rheumatology, Division of Rheumatology, University of Ottawa; G. Tomasson, MD, Department of Public Health Sciences, University of Iceland; J. Dawson, MA, MSc, DPhil, University Research Lecturer and Senior Research Scientist, Nuffield Department of Population Health (HSRU), University of Oxford; P.F. Cronholm, MD, MSCE, FAAFP, Associate Professor, Department of Family Medicine and Community Health, University of Pennsylvania; K. Kellom, BA, Senior Research Coordinator, Department of Family Medicine and Community Health, University of Pennsylvania; J. Shea, PhD, Professor of Medici

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940036PMC
November 2015

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

Eur J Intern Med 2015 Sep 9;26(7):545-53. Epub 2015 May 9.

Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases (Vasculitis, Scleroderma), INSERM U1016, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2015.04.022DOI Listing
September 2015

Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Arthritis Rheumatol 2015 Sep;67(9):2457-65

University of Pennsylvania Perelman School of Medicine, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.39220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949955PMC
September 2015

Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period.

J Cyst Fibros 2015 Jul 16;14(4):526-32. Epub 2015 Feb 16.

Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcf.2015.01.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485936PMC
July 2015

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

J Rheumatol 2015 Jul 15;42(7):1213-7. Epub 2015 Apr 15.

From the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Biostatistics, University of South Florida, Tampa, Florida, USA; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania; The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; University of California at Los Angeles (UCLA), Los Angeles, California, USA.T.A. Kermani, MD, MS, UCLA; K.J. Warrington, MD, Division of Rheumatology, Mayo Clinic College of Medicine; D. Cuthbertson, MS, Department of Biostatistics, University of South Florida; S. Carette, MD, FRCPC, Division of Rheumatology, Mount Sinai Hospital; G.S. Hoffman, MD, MS, Center for Vasculitis Care and Research, Cleveland Clinic; N.A. Khalidi, MD, FRCPC, Division of Rheumatology, St. Joseph's Healthcare, McMaster University; C.L. Koening, MD, MS, Division of Rheumatology, University of Utah; C.A. Langford, MD, MHS, Center for Vasculitis Care and Research, Cleveland Clinic; K. Maksimowicz-McKinnon, DO, Division of Rheumatology and Clinical Immunology, University of Pittsburgh; C.A. McAlear, MA, The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine, and Division of Rheumatology, University of Pennsylvania School of Medicine; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine; P. Seo, MD, MHS, Division of Rheumatology, Johns Hopkins University

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/42/7/1213.full.pdf
Web Search
http://www.jrheum.org/cgi/doi/10.3899/jrheum.141347
Publisher Site
http://dx.doi.org/10.3899/jrheum.141347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505815PMC
July 2015

Cardiac Involvement in Granulomatosis with Polyangiitis.

J Rheumatol 2015 Jul 1;42(7):1209-12. Epub 2015 May 1.

From the Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Health Informatics Institute, University of South Florida, Tampa, Florida; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pennsylvania, Philadelphia; Division of Rheumatology, University of Pittsburgh, Pennsylvania; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Pulmonary and Critical Care Medicine, and the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.L. McGeoch, MD; S. Carette, MD, Division of Rheumatology, Mount Sinai Hospital; D. Cuthbertson, MS, Health Informatics Institute, University of South Florida; G.S. Hoffman, MD, Center for Vasculitis Care and Research, Cleveland Clinic; N. Khalidi, MD, Division of Rheumatology, McMaster University; C.L. Koening, MD, Division of Rheumatology, University of Utah; C.A. Langford, MD, Center for Vasculitis Care and Research, Cleveland Clinic; C.A. McAlear, MA, Division of Rheumatology, University of Pennsylvania; L. Moreland, MD, Division of Rheumatology, University of Pittsburgh; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; P. Seo, MD, Division of Rheumatology, Johns Hopkins University; U. Specks, MD, Division of Pulmonary and Critical Care Medicine; S.R. Ytterberg, MD, Division of Rheumatology, Mayo Clinic College of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; C. Pagnoux, MD, MSc, MPH, Division of Rheumatology, Mount Sinai Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505809PMC
July 2015

Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis.

J Autoimmun 2015 May 3;59:43-52. Epub 2015 Mar 3.

Comprehensive Pneumology Center, Institute of Lung Biology and Disease (iLBD), University Hospital, Ludwig Maximilians University and Helmholtz Zentrum München, Member of the German Center of Lung Research, Max-Lebsche-Platz 31, 81377 Munich, Germany; Max Planck Institute of Neurobiology, Planegg-Martinsried, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2015.02.002DOI Listing
May 2015

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Am J Hum Genet 2015 Apr 26;96(4):565-80. Epub 2015 Mar 26.

Instituto de Parasitología y Biomedicina "López-Neyra," CSIC, PTS Granada, Granada 18016, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2015.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385191PMC
April 2015

Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.

N Engl J Med 2015 Apr;372(16):1510-8

From the Istanbul University Cerrahpasa Medical School, Istanbul (G.H., M.M., C.M., H.Y.), Selçuk University, Konya (R.T., B.T.O.), and Eskişehir Osmangazi University, Eskişehir (C.K.) - all in Turkey; the University of Pennsylvania, Philadelphia (P.A.M.); the Mayo Clinic College of Medicine, Jacksonville, FL (K.T.C.); Celgene, Warren, NJ (Z.L., L.P., R.M.S.); and the New York University Hospital for Joint Diseases, New York (Y.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1408684DOI Listing
April 2015